Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B

Published:2021-09-29 Issue:9 Volume:54 Page:1134-1149
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Liu Zhihong¹^ORCID,Jin Qinglong²,Zhang Yuexin³,Gong Guozhong⁴,Wu Guicheng⁵,Yao Lvfeng⁶,Wen Xiaofeng⁷,Gao Zhiliang¹,Huang Yan⁴,Yang Daokun⁸,Chen Enqiang⁹^ORCID,Mao Qing⁵,Lin Shide¹⁰^ORCID,Shang Jia¹¹,Gong Huanyu⁴,Zhong Lihua¹²,Yin Huafa¹³,Wang Fengmei¹⁴,Hu Peng⁵^ORCID,Xiao Ling¹⁵,Li Chuan¹⁵,Wu Qiong¹⁵,Sun Chang’an¹⁵,Niu Junqi²^ORCID,Hou Jinlin¹^ORCID,

Affiliation:

1. Guangzhou China

2. Changchun China

3. Urumchi China

4. Changsha China

5. Chongqing China

6. Fuzhou China

7. Liuzhou China

8. Xinxiang China

9. Chengdu China

10. Zunyi China

11. Zhengzhou China

12. Harbin China

13. Hefei China

14. Tianjin China

15. Lianyungang China

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16611

Reference48 articles.

1. World Health Organization(2017).Global hepatitis report.https://www.who.int/publications/i/item/global‐hepatitis‐report‐2017. Accessed June 15 2021.

2. Hepatitis B virus infection

3. World Health Organization.Hepatitis B.https://www.who.int/news‐room/fact‐sheets/detail/hepatitis‐b

4. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

5. Countdown to 2030: eliminating hepatitis B disease, China

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study;Antiviral Therapy;2024-09-11

2. Efficacy of tenofovir dipivoxil plus entecavir in patients with HBeAg positive chronic hepatitis B;Tropical Journal of Pharmaceutical Research;2024-09-06

3. Current trends and advances in antiviral therapy for chronic hepatitis B;Chinese Medical Journal;2024-06-28

4. Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China;International Journal of Clinical Pharmacy;2024-03-12

5. Uncovering the mechanism of Tenofovir amibufenamide fumarate punch sticking by combining direct compression experiment and computational simulation;International Journal of Pharmaceutics;2024-03